| Financial Year |
March 31 2023 |
| Monetary Funds |
597,304,719.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,304,513.88 |
| Accounts Receivable |
65,087,187.93 |
| Advances to Suppliers |
17,638,971.16 |
| Other Receivables |
2,063,623.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
120,077,388.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
935,504.50 |
| Total Current Assets |
822,849,281.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
75,522,407.15 |
| Under-construction Projects |
21,723,701.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,306,918.45 |
| R&D expenses |
2,921,415.10 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
762,923.12 |
| Deferred Income Tax Assets |
600,726.08 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
157,960,371.64 |
| Total Assets |
980,809,652.72 |
| Short-Term Loans |
76,457,459.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
43,058,000.00 |
| Accounts Payable |
44,929,409.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,224,066.47 |
| Taxes Payable |
-287,601.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,770,198.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,283,653.08 |
| Other Current Liabilities |
335,414.30 |
| Sub-Total of Current Liabilities |
174,412,556.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
36,505,358.64 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,047,238.67 |
| Total Liabilities |
213,459,794.92 |
| Paid-In Capital(Or Share Stock) |
1,287,210,714.00 |
| Capital Surplus |
536,057,275.88 |
| Surplus Reserve |
74,841,535.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,246,456,913.13 |
| Minority Stockholder's Interest |
123,283,010.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
644,066,847.79 |
| Owner's Equity（Stockholder's Equity） |
767,349,857.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
980,809,652.72 |
